samedan logo

 
 
spacer
home > pmps > summer 2019 > redefining supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Redefining Supply

Passive packaging is coming of age. In a world where door-to-door delivery is transforming the consumer experience, more and more sectors are waking up to the possibilities of delivering temperature-controlled products in a simple, cost-effective, and reliable way.

As the world faces the challenges of global warming, new approaches to packaging also provide opportunities to reassess the impact of supply chains on the planet. However, while industries such as retail and food have been quick to adopt new forms of delivery, they do so without the strict regulations and restraints that often apply to the pharmaceutical sector.

As Managing Director of a company that has invested millions in R&D for passive packaging solutions, I am well aware of both the challenges and benefits they can bring to pharma customers, and, as a passionate believer in the properties of natural materials, I appreciate the particular challenges a more ecological packaging approach presents to this most scientific of sectors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Josie Morris BA (Hons), MA, is Managing Director at The Wool Packaging Company Ltd (Woolcool). A passionate advocate for diversity and the development of strong cultures within innovative businesses, Josie is also closely involved with organisations such as the Bio-Based Industries Association (BBIA), which lobby the UK government on the environmental problems of global packaging waste and support pioneering companies such as Woolcool that offer genuinely sustainable alternatives to plastic materials.
spacer
josie@woolcool.com
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Expands Life Science Production Capacities in the United States

Expansions to significantly increase capacity by end of 2021 to meet unprecedented demand Combined expansion of Danvers, Massachusetts, and Jaffrey, New Hampshire, USA facilities to create nearly 700 new positions Business sector’s announced 2020 investments total more than € 350 million
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement